| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-07-29 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by Knight Therapeutics Inc. | sec.gov ↗ |
| 2026-07-20 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-07-09 | 8-K 8.01 | Other events | sec.gov ↗ |
8-K item codes from the filing header; 13D/G subject and filer verified against the filing index page.
